|
1
|
Chow WH, Dong LM and Devesa SS:
Epidemiology and risk factors for kidney cancer. Nat Rev Urol.
7:245–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Motzer RJ, Jonasch E, Agarwal N, Beard C,
Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh
IH, et al: Kidney cancer, version 3.2015. J Natl Compr Canc Netw.
13:151–159. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Flanigan RC, Campbell SC, Clark JI and
Picken MM: Metastatic renal cell carcinoma. Curr Treat Options
Oncol. 4:385–390. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Afriansyah A, Hamid AR, Mochtar CA and
Umbas R: Targeted therapy for metastatic renal cell carcinoma. Acta
Med Indones. 48:335–347. 2016.PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shui Y, Yu X, Duan R, Bao Q, Wu J, Yuan H
and Ma C: miR-130b-3p inhibits cell invasion and migration by
targeting the Notch ligand Delta-like 1 in breast carcinoma. Gene.
609:80–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang C, Liu T, Huang Y, Qin W, Yang H and
Chen J: MicroRNA-134-3p is a novel potential inhibitor of human
ovarian cancer stem cells by targeting RAB27A. Gene. 605:99–107.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen T, Ren H, Thakur A, Yang T, Li Y,
Zhang S, Wang T and Chen M: miR-382 inhibits tumor progression by
targeting SETD8 in non-small cell lung cancer. Biomed Pharmacother.
86:248–253. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou W, Bi X, Gao G and Sun L: miRNA-133b
and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling
pathway in human renal carcinoma cells. Biomed Pharmacother.
84:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin L, Li Y, Liu J, Yang S, Gui Y, Mao X,
Nie G and Lai Y: Tumor suppressor miR-149-5p is associated with
cellular migration, proliferation and apoptosis in renal cell
carcinoma. Mol Med Rep. 13:5386–5392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kurozumi A, Kato M, Goto Y, Matsushita R,
Nishikawa R, Okato A, Fukumoto I, Ichikawa T and Seki N: Regulation
of the collagen cross-linking enzymes LOXL2 and PLOD2 by
tumor-suppressive microRNA-26a/b in renal cell carcinoma. Int J
Oncol. 48:1837–1846. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim LP, Glasner ME, Yekta S, Burge CB and
Bartel DP: Vertebrate microRNA genes. Science. 299:15402003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu X, He X, Li S, Xu X, Chen X and Zhu H:
Long Non-Coding RNA ucoo2kmd.1 regulates CD44-dependent cell growth
by competing for miR-211-3p in colorectal cancer. PLoS One.
11:e01512872016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang CY, Hua L, Sun J, Yao KH, Chen JT,
Zhang JJ and Hu JH: MiR-211 inhibits cell proliferation and
invasion of gastric cancer by down-regulating SOX4. Int J Clin Exp
Pathol. 8:14013–14020. 2015.PubMed/NCBI
|
|
15
|
Ye L, Wang H and Liu B: miR-211 promotes
non-small cell lung cancer proliferation by targeting SRCIN1.
Tumour Biol. 37:1151–1157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang G, Cui Y, Yu X, Wu Z, Ding G and Cao
L: miR-211 suppresses hepatocellular carcinoma by downregulating
SATB2. Oncotarget. 6:9457–9466. 2015.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia B, Yang S, Liu T and Lou G: miR-211
suppresses epithelial ovarian cancer proliferation and cell-cycle
progression by targeting Cyclin D1 and CDK6. Mol Cancer. 14:572015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng T, Wang L, Li Y, Huang C, Zeng L and
Yang J: Differential microRNA expression in renal cell carcinoma.
Oncol Lett. 6:769–776. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang K, Jin W, Jin P, Fei X, Wang X and
Chen X: miR-211-5p suppresses metastatic behavior by targeting
SNAI1 in renal cancer. Mol Cancer Res. 15:448–456. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu J, Zhang R and Zhao J: The novel long
noncoding RNA TUSC7 inhibits proliferation by sponging MiR-211 in
colorectal cancer. Cell Physiol Biochem. 41:635–644. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sümbül AT, Göğebakan B, Bayram S, Batmacı
CY and Öztuzcu S: MicroRNA 211 expression is upregulated and
associated with poor prognosis in colorectal cancer: A case-control
study. Tumour Biol. 36:9703–9709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Y, Byon CH, Yuan K, Chen J, Mao X,
Heath JM, Javed A, Zhang K, Anderson PG and Chen Y: Smooth muscle
cell-specific runx2 deficiency inhibits vascular calcification.
Circ Res. 111:543–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Atlasi Y, Noori R, Gaspar C, Franken P,
Sacchetti A, Rafati H, Mahmoudi T, Decraene C, Calin GA, Merrill BJ
and Fodde R: Wnt signaling regulates the lineage differentiation
potential of mouse embryonic stem cells through Tcf3
down-regulation. PLoS Genet. 9:e10034242013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Panizo S, Naves-Díaz M, Carrillo-López N,
Martínez-Arias L, Fernández-Martín JL, Ruiz-Torres MP,
Cannata-Andía JB and Rodríguez I: MicroRNAs 29b, 133b and 211
regulate vascular smooth muscle calcification mediated by high
phosphorus. J Am Soc Nephrol. 27:824–834. 2016. View Article : Google Scholar : PubMed/NCBI
|
